Skip to main content
gfb banner eng

CRISPRCAS9 THERAPY

FOR SARCOGLICANOPATHIES

C.A.R.E. LGMD PROGRAM

| CrisprCas9 therapy

There is an ongoing study for LGMD2i and LGMD2G in the United States.
https://thespeakfoundation.com/c-a-r-e-program?fbclid=IwAR12xyRwqj82REvpPlvAPeE_sl0wRKbzZxwIBPfRIzSK5ENjX3Omo3vsCsg